Table 5B.
Comparison of lab values and MLHFQ from baseline to end of observation (last carried forward) according to the treatment arm.
| eGFR | <60 ml/min/1.73 m 2 | ≥60 ml/min/1.73 m 2 | ||||
|---|---|---|---|---|---|---|
| Group | RPM | UC | p -value | RPM | UC | p -value |
| N | N = 433 | N = 445 | N = 332 | N = 328 | ||
| Creatinine (mg/dl) | 0.1 (−0.1 to +0.3) | −0.1 (−0.4 to +0.3) | 0.04 | 0.1 (−0 to +0.2) | 0 (−0.1 to +0.2) | 0.02 |
| eGFR (ml/min/1.73 m2) | −2 (−10 to +3) | −1 (−8 to +5) | 0.02 | −5 (−17 to +2) | −4 (−12 to +3) | 0.02 |
| Potassium (mmol/l) | 0 (−0.5 to +0.3) | 0 (−0.4 to +0.3) | 0.9 | 0 (−0.4 to +0.2) | 0 (−0.3 to +0.4) | 0.05 |
| Sodium (mmol/l) | 0 (−2 to +2) | 0 (−2 to +2) | 0.5 | 0 (−2 to +3) | 0 (−2 to +2) | 0.1 |
| Hematocrit (%) | 0 (−3 to +2) | 0 (−2.7 to +2) | 0.7 | 0 (−3 to +2) | 0 (−2.7 to +2) | 0.9 |
| Hemoglobin (g/dl) | 0 (−0.8 to +0.6) | 0 (−0.8 to +0.6) | 0.8 | −0.2 (−1 to +0.6) | 0 (−0.9 to +0.6) | 0.2 |
| NT-pro BNP (pg/ml) | −17 (−713 to +532) | 0 (−577 to +862) | 0.3 | −93 (−540 to +111) | −134 (−616 to +178) | 0.7 |
| MLHFQ | 0.06 | 0.5 | ||||
| Global Score | −1.9 (−11.9 to +5) | 0 (−9.9 to +7.4) | −1 (−11 to +7.3) | −1.1 (-13 to +6.1) | ||
Data are median and IQR. eGFR, estimated glomerular filtration rate; MLHFQ, Minnesota Living with heart failure questionnaire; RPM, remote patient management; UC, usual care. p-value was calculated using Mann–Whitney U.